Experimental study on the treatment of norepinephrine transporter-overexpressing pheochromocytomas and paragangliomas: a synthetic lethality strategy combining 131I-MIBG with PARP inhibitors. This evidence concerns the gene PARP1 and hereditary pheochromocytoma-paraganglioma.